Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
121 Seaport Blvd Boston, Massachusetts US
Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. by AstraZeneca. For more than 30 years, Alexion
Headcount: 1,500 Bio/Pharma Revenues: $1,1344 (5%) Total Revenues: $1,134 (5%) Net Income: $2554 (6%) R&D Budget: $2236 (3%)
Top Selling Drugs
Account for 100% of total biopharma sales, same as in 2011
Headcount: 792 Pharma Revenues: $541 (40%) Total Revenues: $541 (40%) Net Income: $91 (-69%) R&D Budget: $98 (20%)
Top-Selling Drugs in 2010
Drug
Indication
(+/- %)
Soliris
paroxysmal nocturnal hemoglobinuria (PNH)
Account for 100% of total biopharma sales, same as in 2009.
Previous Profile: Allergan
Headcount: 12,000 Bio/pharma Revenues: $3,562 (-5%) Total Revenues: $4,516 (-2%) Net Income: $422 (flat) R&D Budget: $865 (-34%)
Account for 82% of total bio/pharma sales, same as in 2008.
45 Poplar Rd., Parkville Victoria 3052, Australia Tel: +61 3 9389 1911 Fax: +61 3 9389 1434 www.csl.com.au
Revenues converted at average exchange rate / based on reported currency (AUD)
Account for 67% of total bio/pharma sales, up from 65% in 2008.
NOTE: CSL’s fiscal year runs from July 1, 2007 to June 30, 2008.
2525 Dupont Dr. Irvine, CA 92612 Tel: (714) 246-4500 Fax: (714) 246-4971 www.allergan.com
Account for 100% of total bio/pharma sales, same as in 2008.
325 Knotter Dr. Cheshire, CT 06410 Tel: (203) 272-ALXN (2596) Fax: (203) 271-8198 www.alexionpharma.com
Return to Top Biopharma Report homepage.
CSL will pay VarmX shareholders $117 million upfront for an exclusive option to acquire the company.
By: Charlie Sternberg
Provides the Morgpeth facility’s Formulation Development Team with an important tool for developing fixed dose combinations and modified release drug delivery.
Will offer a streamlined workflow from sample receipt and storage through advanced molecular analysis.
Brown brings extensive international experience across oncology and radiopharmaceutical development.
By: Rachel Klemovitch
Takeda will transport its products using VELA’s new fleet of next-generation sailing cargo vessels, powered 100 percent by wind when at sea.
Monte Rosa to apply its QuEEN product engine for the discovery and development of degraders to be further developed and commercialized by Novartis.
Designed to further enable process optimization by maximizing cell growth, viability, and productivity for a wide range of applications.
Designed to increase titers and enhance bioprocessing performance of insulin-dependent CHO cell lines.
Bartley will lead day-to-day operations and growth across Chrysalis’ cleanroom infrastructure, environmental monitoring, and support service teams.
The $225 million acquisition includes BioReference Health's laboratory testing businesses focused on oncology and oncology-related clinical testing services.
Maria Soler Nunez will take up the newly-created role of Chief Quality Officer.
Enbumyst is the first and only intranasal loop diuretic approved in the U.S., offering a self-administered alternative between oral and intravenous diuretics.
Enhances its AbZelectPRO cell line development platform.
Bilenberg is a seasoned industry executive with more than 20 years of experience.
With over 30 years of experience, Reed will advance strategic priorities, operations, and promote long-term growth.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
